AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32035020 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant plus capivasertib (400 mg orally twice daily on an intermittent weekly schedule)
Number of subjects: 140
Study 32035020 — intervention group
Group type: COMPARATOR
Intervention: Fulvestrant plus placebo
Number of subjects: 140
Study 35797557 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular fish skin graft
Number of subjects: 94
Study 35797557 — intervention group
Group type: COMPARATOR
Intervention: Collagen alginate dressing
Number of subjects: 94
Study 33798304 — intervention group
Group type: EXPERIMENTAL
Intervention: Bushen Tiaodu Yizhi acupuncture combined with computer‐assisted cognitive training
Number of subjects: 98
Study 33798304 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment with acupuncture at acupoints of limbs
Number of subjects: 98
Study 32609022 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% zinc sulfate
Number of subjects: 152
Study 32609022 — intervention group
Group type: EXPERIMENTAL
Intervention: vitamin D3
Number of subjects: 152
Study 32609022 — intervention group
Group type: EXPERIMENTAL
Intervention: Candida antigen
Number of subjects: 152
Study 32609022 — intervention group
Group type: COMPARATOR
Intervention: normal saline
Number of subjects: 152
Study 34237262 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG revaccination
Number of subjects: 46889
Study 34237262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46889
Study 32446145 — intervention group
Group type: EXPERIMENTAL
Intervention: Regorafenib
Number of subjects: 758
Study 32446145 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 758
Study 36190011 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin, 10 mg, once daily
Number of subjects: 6263
Study 33989711 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 777
Study 33989711 — intervention group
Group type: COMPARATOR
Intervention: Conservative strategy
Number of subjects: 777
Study 33274895 — intervention group
Group type: EXPERIMENTAL
Intervention: Foliar application of algae at 8 g L‐1
Number of subjects: 0
Study 33274895 — intervention group
Group type: EXPERIMENTAL
Intervention: Foliar application of yeast
Number of subjects: 0
Study 33274895 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (foliar water)
Number of subjects: 0
Study 34412973 — intervention group
Group type: EXPERIMENTAL
Intervention: HCG (500 IU in 0.1 ml of tissue culture media)
Number of subjects: 181
Study 34412973 — intervention group
Group type: COMPARATOR
Intervention: Culture media (0.1 ml of tissue culture media)
Number of subjects: 181
Study 33028361 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasmodium falciparum infection
Number of subjects: 400
Study 33028361 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild anaemia in P. falciparum-infected children
Number of subjects: 400
Study 33028361 — intervention group
Group type: EXPERIMENTAL
Intervention: Underweight
Number of subjects: 400
Study 33028361 — intervention group
Group type: EXPERIMENTAL
Intervention: Residence near water collections
Number of subjects: 400
Study 33028361 — intervention group
Group type: EXPERIMENTAL
Intervention: Total white blood cells, monocytes, and platelets
Number of subjects: 400
Study 33028361 — intervention group
Group type: EXPERIMENTAL
Intervention: Malnutrition
Number of subjects: 400
Study 33400432 — intervention group
Group type: EXPERIMENTAL
Intervention: High-voltage PRF combined with low-temperature CRF (70 V, 42°C, 2 Hz, pulse width 20 ms, treatment time 600 s; CRF at 60°C, treatment time 270 s)
Number of subjects: 146
Study 33400432 — intervention group
Group type: COMPARATOR
Intervention: High-voltage PRF only (70 V, 42°C, 2 Hz, pulse width 20 ms, treatment time 600 s)
Number of subjects: 146
Study 33400432 — intervention group
Group type: EXPERIMENTAL
Intervention: High-voltage PRF combined with low-temperature CRF
Number of subjects: 146
Study 33400432 — intervention group
Group type: COMPARATOR
Intervention: High-voltage PRF only
Number of subjects: 146
Study 32277977 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy Resistance Training (HRT, n=149, 3/wk)
Number of subjects: 451
Study 32277977 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Intensity Resistance Training (MIT, n=154, 3/wk)
Number of subjects: 451
Study 32277977 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise activities (CON, n=148)
Number of subjects: 451
Study 35658942 — intervention group
Group type: EXPERIMENTAL
Intervention: Unguided iCBT
Number of subjects: 1500
Study 35658942 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided iCBT
Number of subjects: 1500
Study 35658942 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 1500
Study 32538008 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS) applied at specific acupoints on days 1, 2, 3, 5, 8, 14, 21, and 28 of chemotherapy, 30 minutes each time, once a day.
Number of subjects: 102
Study 32538008 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication group received DiyuShengbai tablets before chemotherapy, 2-3 tablets each time, 3 times a day.
Number of subjects: 102
Study 32538008 — intervention group
Group type: COMPARATOR
Intervention: TEAS group
Number of subjects: 102
Study 32538008 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (chemotherapy with gemcitabine and cisplatin plus routine care)
Number of subjects: 102
Study 35980949 — intervention group
Group type: EXPERIMENTAL
Intervention: EGFR mutation
Number of subjects: 1001
Study 35980949 — intervention group
Group type: EXPERIMENTAL
Intervention: HER2 mutation
Number of subjects: 1001
Study 35980949 — intervention group
Group type: EXPERIMENTAL
Intervention: BRAF mutation
Number of subjects: 1001
Study 35980949 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusion mutation (ALK and ROS1)
Number of subjects: 1001
Study 35980949 — intervention group
Group type: EXPERIMENTAL
Intervention: KRAS mutation
Number of subjects: 1001
Study 35980949 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-adenocarcinoma histology
Number of subjects: 1001
Study 35980949 — intervention group
Group type: EXPERIMENTAL
Intervention: ROS-1 rearranged patients with strong PD-L1 expression
Number of subjects: 1001
Study 35980949 — intervention group
Group type: EXPERIMENTAL
Intervention: KRAS-mutant patients with strong PD-L1 expression
Number of subjects: 1001
Study 33189857 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS with sham MCAT treatment
Number of subjects: 100
Study 33189857 — intervention group
Group type: EXPERIMENTAL
Intervention: MCAT with sham tDCS
Number of subjects: 100
Study 33189857 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined tDCS and MCAT
Number of subjects: 100
Study 33189857 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS and sham MCAT
Number of subjects: 100
Study 35254460 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1: Two parallel longitudinal screws and two screws fixing the intraarticular posterior facet fracture line
Number of subjects: 15
Study 35254460 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2: Two screws entered the tuberosity inferiorly to the Achilles tendon insertion and two transverse screws fixed the posterior facet
Number of subjects: 15
Study 35254460 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3: Two screws inserted along the bone axis, one transverse screw fixed the posterior facet and one oblique screw inserted from the posteroplantar part of the tuberosity
Number of subjects: 15
Study 34678874 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi exercise
Number of subjects: 272
Study 34678874 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 272
Study 34475178 — intervention group
Group type: EXPERIMENTAL
Intervention: CDTI plus annual SC for 2 years
Number of subjects: 8
Study 34475178 — intervention group
Group type: COMPARATOR
Intervention: CDTI only for two consecutive years
Number of subjects: 8
Study 35787211 — intervention group
Group type: EXPERIMENTAL
Intervention: FiberStich (knotless soft anchoring)
Number of subjects: 60
Study 35787211 — intervention group
Group type: COMPARATOR
Intervention: IO-S (inside-out suture repair)
Number of subjects: 60
Study 35787211 — intervention group
Group type: EXPERIMENTAL
Intervention: IO-ST (inside-out suture tape)
Number of subjects: 60
Study 35787211 — intervention group
Group type: EXPERIMENTAL
Intervention: FastFix 360
Number of subjects: 60
Study 35787211 — intervention group
Group type: EXPERIMENTAL
Intervention: Stryker AIR
Number of subjects: 60
Study 35787211 — intervention group
Group type: EXPERIMENTAL
Intervention: TrueSpan
Number of subjects: 60
Study 35787211 — intervention group
Group type: EXPERIMENTAL
Intervention: FiberStich
Number of subjects: 60
Study 33419698 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration guidance CPR
Number of subjects: 130
Study 33419698 — intervention group
Group type: COMPARATOR
Intervention: Metronome guidance CPR
Number of subjects: 130
Study 32571263 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals self-identifying as having or having had a prescription drug abuse issue
Number of subjects: 631
Study 32571263 — intervention group
Group type: EXPERIMENTAL
Intervention: Male respondents
Number of subjects: 631
Study 32571263 — intervention group
Group type: EXPERIMENTAL
Intervention: Older respondents (55+)
Number of subjects: 631
Study 32571263 — intervention group
Group type: EXPERIMENTAL
Intervention: Male and younger respondents
Number of subjects: 631
Study 36336989 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclopirox nail hydrolacquer
Number of subjects: 381
Study 36336989 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 381
Study 36336989 — intervention group
Group type: COMPARATOR
Intervention: Reference product (hydroxypropyl chitosan‐based 80 mg/g ciclopirox nail lacquer)
Number of subjects: 381
Study 36336989 — intervention group
Group type: COMPARATOR
Intervention: Reference product
Number of subjects: 381
Study 33567047 — intervention group
Group type: EXPERIMENTAL
Intervention: NPWT + PRP gel
Number of subjects: 102
Study 33567047 — intervention group
Group type: COMPARATOR
Intervention: NPWT
Number of subjects: 102
Study 32303260 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive behavioural therapy program (10 two-hour weekly sessions)
Number of subjects: 24
Study 35544074 — intervention group
Group type: EXPERIMENTAL
Intervention: 3BNC117 plus romidepsin
Number of subjects: 22
Study 35544074 — intervention group
Group type: COMPARATOR
Intervention: romidepsin
Number of subjects: 22
Study 33861679 — intervention group
Group type: EXPERIMENTAL
Intervention: Sabin inactivated poliovirus vaccine (sIPV)
Number of subjects: 250
Study 35180260 — intervention group
Group type: EXPERIMENTAL
Intervention: Clown visits by RED NOSES Clowndoctors Austria on a weekly basis over four consecutive weeks
Number of subjects: 50
Study 35180260 — intervention group
Group type: EXPERIMENTAL
Intervention: Clown visits
Number of subjects: 50
Study 33407263 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued annual mass azithromycin distribution
Number of subjects: 0
Study 33407263 — intervention group
Group type: COMPARATOR
Intervention: Stopping annual azithromycin distribution
Number of subjects: 0
Study 32542869 — intervention group
Group type: EXPERIMENTAL
Intervention: Transepidermal application of CO2 (twice daily for 1 week)
Number of subjects: 20
Study 32542869 — intervention group
Group type: COMPARATOR
Intervention: Formulation containing hydrochloric acid (control)
Number of subjects: 20
Study 36454865 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessed push-up test via ecofit app
Number of subjects: 54
Study 36454865 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessed sit-to-stand test via ecofit app
Number of subjects: 54
Study 32833584 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia
Number of subjects: 20
Study 32833584 — intervention group
Group type: COMPARATOR
Intervention: Normothermia (later comparison)
Number of subjects: 20
Study 35871338 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal exercise program with omega-3 (900 mg EPA, 600 mg DHA), vitamin D (1000 IU), and protein (20 g) supplement (n=73)
Number of subjects: 147
Study 35871338 — intervention group
Group type: COMPARATOR
Intervention: Control condition with stretching/flexibility sessions and placebo (n=74)
Number of subjects: 147
Study 35871338 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal exercise program with omega-3, vitamin D, and protein supplement (n=73)
Number of subjects: 147
Study 33549192 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimekizumab 320 mg every 4 weeks
Number of subjects: 435
Study 33549192 — intervention group
Group type: COMPARATOR
Intervention: Placebo every 4 weeks
Number of subjects: 435
Study 33549192 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimekizumab 320 mg every 8 weeks
Number of subjects: 435
Study 33549192 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 435
Study 33407609 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomato sauce (OsteoCol) 150 ml/day
Number of subjects: 108
Study 33407609 — intervention group
Group type: COMPARATOR
Intervention: Sterol-enriched yogurt (1.6 g/die)
Number of subjects: 108
Study 35125237 — intervention group
Group type: EXPERIMENTAL
Intervention: Acu-TENS (transcutaneous electrical acupoint stimulation)
Number of subjects: 40
Study 35125237 — intervention group
Group type: COMPARATOR
Intervention: Sham Acu-TENS
Number of subjects: 40
Study 34672147 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate work rate (30 W/min)
Number of subjects: 12
Study 34672147 — intervention group
Group type: EXPERIMENTAL
Intervention: Low work rate (10 W/min)
Number of subjects: 12
Study 34672147 — intervention group
Group type: EXPERIMENTAL
Intervention: High work rate (60 W/min)
Number of subjects: 12
Study 32159711 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment as usual plus immediate access to Deprexis
Number of subjects: 128
Study 32159711 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual plus delayed access to Deprexis (after 8 weeks)
Number of subjects: 128
Study 35103537 — intervention group
Group type: EXPERIMENTAL
Intervention: DBT plus DM
Number of subjects: 26877
Study 35103537 — intervention group
Group type: COMPARATOR
Intervention: DM
Number of subjects: 26877
Study 34471452 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching Recovery Techniques (TRT)
Number of subjects: 30
Study 34471452 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (boxing/martial arts)
Number of subjects: 30
Study 36128636 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-on PEG-IFN
Number of subjects: 153
Study 36128636 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch to PEG-IFN
Number of subjects: 153
Study 36128636 — intervention group
Group type: COMPARATOR
Intervention: Continuous entecavir monotherapy
Number of subjects: 153
Study 33278364 — intervention group
Group type: EXPERIMENTAL
Intervention: Perturbation-based pinch task training (20 minutes per session, twice a week for 6 weeks)
Number of subjects: 19
Study 33278364 — intervention group
Group type: COMPARATOR
Intervention: Task-specific motor training (20 minutes per session, twice a week for 6 weeks)
Number of subjects: 19
Study 35704394 — intervention group
Group type: COMPARATOR
Intervention: OnabotulinumtoxinA 20 U
Number of subjects: 226
Study 35704394 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 40 U
Number of subjects: 226
Study 35704394 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 60 U
Number of subjects: 226
Study 35704394 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 80 U
Number of subjects: 226
Study 35704394 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (all higher doses)
Number of subjects: 226
Study 35704394 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial Line Satisfaction Questionnaire
Number of subjects: 226
Study 35704394 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment-emergent adverse events
Number of subjects: 226
Study 34129025 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 773
Study 34129025 — intervention group
Group type: COMPARATOR
Intervention: Landmark models using current PSA alone
Number of subjects: 773
Study 34129025 — intervention group
Group type: COMPARATOR
Intervention: Joint models with linear vs nonlinear PSA
Number of subjects: 773
Study 32859388 — intervention group
Group type: EXPERIMENTAL
Intervention: CD144 expression
Number of subjects: 173
Study 32859388 — intervention group
Group type: EXPERIMENTAL
Intervention: Borrmann type and CD144 expression
Number of subjects: 173
Study 35773804 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based digital game during the course
Number of subjects: 60
Study 35773804 — intervention group
Group type: COMPARATOR
Intervention: Traditional instructional activities
Number of subjects: 60
Study 34596556 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel distributed primal‐dual fixed point algorithm based on an adapted metric method.
Number of subjects: 0
Study 34596556 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized asynchronous iterative distributed algorithm with randomized coordinate activation mechanism.
Number of subjects: 0
Study 32594915 — intervention group
Group type: EXPERIMENTAL
Intervention: Purple Wheat (PW)
Number of subjects: 29
Study 32594915 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular Wheat (RW)
Number of subjects: 29
Study 32594915 — intervention group
Group type: COMPARATOR
Intervention: Comparison between PW and RW
Number of subjects: 29
Study 35271478 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral lactoferrin supplementation (100 mg/day until PMA of 36 weeks or discharge)
Number of subjects: 117
Study 35271478 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 117
Study 34173129 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral octreotide capsules (OOC) in CH‐ACM‐01 trial
Number of subjects: 211
Study 34173129 — intervention group
Group type: COMPARATOR
Intervention: Oral octreotide capsules (OOC) in CHIASMA OPTIMAL trial
Number of subjects: 211
Study 34173129 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral octreotide capsules (OOC) in both trials
Number of subjects: 211
Study 35131832 — intervention group
Group type: EXPERIMENTAL
Intervention: No/Partial Smoke-Free Home Restrictions (SFH) among non-smokers in Armenia
Number of subjects: 1456
Study 35131832 — intervention group
Group type: EXPERIMENTAL
Intervention: No/Partial Smoke-Free Home Restrictions (SFH) among smokers in Armenia
Number of subjects: 1456
Study 35131832 — intervention group
Group type: EXPERIMENTAL
Intervention: No/Partial Smoke-Free Home Restrictions (SFH) among non-smokers in Georgia
Number of subjects: 1456
Study 35131832 — intervention group
Group type: EXPERIMENTAL
Intervention: No/Partial Smoke-Free Home Restrictions (SFH) among smokers in Georgia
Number of subjects: 1456
Study 33155461 — intervention group
Group type: EXPERIMENTAL
Intervention: IV acetaminophen and IM pethidine (Group A)
Number of subjects: 316
Study 33155461 — intervention group
Group type: EXPERIMENTAL
Intervention: IV acetaminophen and IV parecoxib (Group B)
Number of subjects: 316
Study 33155461 — intervention group
Group type: COMPARATOR
Intervention: IV acetaminophen monotherapy (Group C)
Number of subjects: 316
Study 32061444 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-step characterization (SC) with one firing cycle (850°C/10min)
Number of subjects: 30
Study 32061444 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-step characterization (DC) with crystallization followed by staining
Number of subjects: 30
Study 32061444 — intervention group
Group type: COMPARATOR
Intervention: Control (CO) with crystallization (850°C/10min)
Number of subjects: 30
Study 32061444 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated firings (2, 4, or 6 times)
Number of subjects: 30
Study 35905310 — intervention group
Group type: EXPERIMENTAL
Intervention: CNN-based deep learning algorithm using lateral cervical spine radiographs
Number of subjects: 187
Study 35653761 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily skin-to-skin contact (SSC) for 1 hour daily for the first 5 weeks postpartum
Number of subjects: 116
Study 35653761 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 116
Study 35653761 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily skin-to-skin contact (SSC)
Number of subjects: 116
Study 36494849 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic radial artery harvest
Number of subjects: 300
Study 36494849 — intervention group
Group type: COMPARATOR
Intervention: Open radial artery harvest
Number of subjects: 300
Study 36494849 — intervention group
Group type: EXPERIMENTAL
Intervention: Aorto-radial anastomosis
Number of subjects: 300
Study 36494849 — intervention group
Group type: COMPARATOR
Intervention: Mammario-radial anastomosis
Number of subjects: 300
Study 34695804 — intervention group
Group type: EXPERIMENTAL
Intervention: Nudges including contextual cues (painted footpath from toilet to handwashing station) and visible reminders (posters and eye sticker)
Number of subjects: 132
Study 34695804 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nudges)
Number of subjects: 132
Study 34695804 — intervention group
Group type: EXPERIMENTAL
Intervention: Nudges including contextual cues and visible reminders
Number of subjects: 132
Study 33124989 — intervention group
Group type: EXPERIMENTAL
Intervention: KhunLook mobile app
Number of subjects: 356
Study 33124989 — intervention group
Group type: COMPARATOR
Intervention: MCHH
Number of subjects: 356
Study 616775476 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus coryniformis CECT5711 strain as a coadjuvant in a vaccination process
Number of subjects: 0
Study 616775476 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 36007710 — intervention group
Group type: EXPERIMENTAL
Intervention: Sperm processed using microfluidics
Number of subjects: 1372
Study 36007710 — intervention group
Group type: COMPARATOR
Intervention: Sperm processed using density gradient centrifugation
Number of subjects: 1372
Study 34385241 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide 160 mg/day plus LHRHa
Number of subjects: 1050
Study 34385241 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide monotherapy
Number of subjects: 1050
Study 34385241 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus LHRHa
Number of subjects: 1050
Study 35371278 — intervention group
Group type: EXPERIMENTAL
Intervention: ESWT combined with wIRA therapy
Number of subjects: 120